🇺🇸 FDA
Patent

US 8653034

Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 8653034 (Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives) held by The Board of Regents of the University of Texas System expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/62